Virtu Financial’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,521
| Closed | -$7K | – | 2385 |
|
|
2023
Q1 | $7K | Buy |
12,521
+953
| +8% | +$758 | ﹤0.01% | 1381 |
|
|
2022
Q4 | $8K | Buy |
11,568
+8,404
| +266% | +$13.7K | ﹤0.01% | 1420 |
|
|
2022
Q3 | $9K | Sell |
3,164
-1,958
| -38% | -$7.39K | ﹤0.01% | 1535 |
|
|
2022
Q2 | $23K | Buy |
+5,122
| New | +$22.5K | ﹤0.01% | 1308 |
|
|
2022
Q1 | – | Sell |
-9,427
| Closed | -$64K | – | 2320 |
|
|
2021
Q4 | $64K | Buy |
+9,427
| New | +$96.5K | 0.01% | 1276 |
|
|
2021
Q3 | – | Sell |
-4,101
| Closed | -$77K | – | 2164 |
|
|
2021
Q2 | $77K | Sell |
4,101
-3,741
| -48% | -$69.7K | 0.01% | 1261 |
|
|
2021
Q1 | $182K | Buy |
7,842
+3,809
| +94% | +$96.5K | 0.01% | 1123 |
|
|
2020
Q4 | $56K | Buy |
+4,033
| New | +$59.6K | 0.01% | 1211 |
|
|
2019
Q3 | – | Sell |
-966
| Closed | -$24K | – | 1959 |
|
|
2019
Q2 | $24K | Sell |
966
-375
| -28% | -$11.7K | ﹤0.01% | 1327 |
|
|
2019
Q1 | $48K | Buy |
+1,341
| New | +$55.1K | ﹤0.01% | 1215 |
|
|
2018
Q4 | – | Sell |
-303
| Closed | -$47K | – | 2094 |
|
|
2018
Q3 | $47K | Buy |
+303
| New | +$44.8K | ﹤0.01% | 1311 |
|
|
2018
Q2 | – | Sell |
-197
| Closed | -$49K | – | 2640 |
|
|
2018
Q1 | $49K | Buy |
197
+15
| +8% | +$4.22K | ﹤0.01% | 1722 |
|
|
2017
Q4 | $50K | Buy |
182
+58
| +47% | +$22.1K | ﹤0.01% | 2078 |
|
|
2017
Q3 | $50K | Buy |
+124
| New | +$64.6K | ﹤0.01% | 2229 |
|
Other funds holding VYNT
Virtu Financial's VYNT Position: Q2 2023 in Review
Virtu Financial sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 12,521 shares — an estimated $7K sold.
Virtu Financial first reported a position in VYNT in Q3 2017 and held it in 14 quarters. The position peaked at $182K in Q1 2021. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- Virtu Financial reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Virtu Financial sold 12,521 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $7K.
- Virtu Financial first reported a position in Vyant Bio, Inc. Common Stock in Q3 2017 and held it in 14 quarters.
- Virtu Financial's Vyant Bio, Inc. Common Stock position peaked at $182K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.
Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.